A comprehensive review of 44 studies using single-cell RNA sequencing (scRNA-seq) identifies cellular traits that differentiate durable cancer responses from relapse in CAR-T cell therapy. The analysis of 500 patients highlights the roles of exhaustion, cytotoxicity, memory, and clonal diversity in treatment outcomes, offering insights for improving long-term remission rates.
In a groundbreaking review published in Trends in Molecular Medicine, researchers in the United States have synthesized findings from 44 studies using single-cell RNA sequencing (scRNA-seq) to identify key cellular traits that distinguish durable cancer responses from relapse in patients undergoing CAR-T cell therapy.
Chimeric antigen receptor T cell (CAR-T) therapy, a landmark achievement in modern medicine, involves genetically engineering a patient’s immune cells to target and destroy cancer. While this approach has led to long-term remissions in previously untreatable leukemias and lymphomas, a significant portion of patients still experience relapse or resistance. Historically, researchers could only study these cells in bulk, averaging the behavior of millions of cells at once.
This lack of granularity obscured the differences between highly effective cells and exhausted ones, potentially leading to incomplete conclusions. The advent of scRNA-seq has revolutionized this field by allowing high-resolution analysis of individual cells, offering insights into why some therapies persist long-term while others fail prematurely. The review analyzed data from 500 patients, primarily with hematological malignancies such as B-cell lymphoma, acute lymphoblastic leukemia (ALL), multiple myeloma, and solid or brain tumors.
The studies predominantly used 10X Genomics data from infusion products, peripheral blood, bone marrow, and other sources, focusing on key phenotypes like exhaustion, cytotoxicity, memory and stemness, and clonal diversity. One of the most consistent findings was that cellular exhaustion, marked by high expression of genes like LAG3, PDCD1 (PD-1), and HAVCR2 (TIM-3), correlated with poor clinical outcomes. Patients who did not respond to therapy or relapsed early showed higher levels of these exhaustion markers.
Conversely, better responses were linked to infusion products enriched with memory-like cells, which must differentiate into cytotoxic cells to eliminate tumors. The review also highlighted the importance of clonal dynamics, with long-term responders often exhibiting highly expanded persistent CAR-T cell clones, though patterns varied by disease and study. The majority of sequenced patients received CAR-T cells targeting CD19, the most common marker for B-cell cancers.
Emerging research suggests that scRNA-seq can also track CAR-T cell activity in brain tumors, despite challenges posed by the blood-brain barrier. Early studies analyzing cerebrospinal fluid (CSF) and tumor samples indicate that scRNA-seq can help monitor immune remodeling in central nervous system settings, though more research is needed due to limited sample numbers and difficulties in obtaining representative tumor samples.
These findings underscore the potential of single-cell analysis to refine CAR-T therapy, optimize patient outcomes, and pave the way for more personalized cancer treatments
CAR-T Cell Therapy Single-Cell RNA Sequencing Cancer Treatment Cellular Exhaustion Clonal Diversity
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'£300' car insurance rules for all drivers - police can seize carMotoring experts have urged people to triple check what they are doing
Read more »
Study provides roadmap for safer pharmaceutical analysis methodsA new doctoral thesis at Karlstad University provides increased understanding of how medicines can be analysed more reliably and safely.
Read more »
New imaging method maps DNA replication forks with single-cell resolutionResearchers at The University of Texas MD Anderson Cancer Center have developed a new imaging method, known as RF-SIRF, that quantitatively detects and maps reversed DNA replication forks with single-cell resolution
Read more »
Oracle plans to power its New Mexico mega datacenter with a 2.45GW fuel cell farm: No sense in OpenAI stressing over its cloud bills if Oracle can't get the lights on
Read more »
Where to watch every single 2025/26 Premier League, Champions League and EFL gameThe 2025/26 football season is nearly over, but there are still some huge games to play. Here's your TV guide to watching every end-of-season Premier League, Champions League and EFL fixture
Read more »
Eating creates temporary metabolic state that boosts T cell functionDiets and healthy eating habits hold promise for preventing and treating diseases, but far less is known about acute effects to the immune system shortly after a meal.
Read more »